OCT 28, 2021 8:00 AM PDT

How to Advance Cell & Gene Therapies with an Innovative, Flexible Approach

Sponsored by: Dassault Systèmes

Event Date & Time
Date:  October 28, 2021
Time: 8:00am (PDT),  11:00am (EDT)
Today’s health industry is leveraging new, cutting-edge Cell & Gene Therapies (CGTs) to address a variety of medical illnesses and conditions that presently have no other treatments (e.g., gene therapies and CAR-T cell approaches to fight many types of cancer). Most CGT challenges relate to scalability and manufacturability. The circular CGT supply chain, with its highly personalized and novel therapies, is complex and variable. It requires strict collaboration among R&D, CMOs/CDMOs and hospitals. Most importantly, CGT treatments are “Live Drugs” incorporating ex vivo, in culture and in vivo therapies. This talk will cover the critical, end-to-end manufacturing analytics, laboratory informatics, and process performance reporting solutions required to drive innovation, reduce costs and accelerate Cell & Gene Therapies to patients.
Learning Objectives
  • Discover the interdependence of different domains along the product life cycle of CGTs
  • Discuss how targeted solutions can simplify the workflow complexity in development, manufacturing and testing of CGTs
  • Discuss and learn about the impact of connected scientific informatics to optimize CGT development
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

You May Also Like
Loading Comments...